Uncategorized - May 30, 2024
Designates David Heidecorn as successor to Ophir Sternberg as Chairman of the Board Enters retention agreements with executive leadership to […]
Read More
Uncategorized - May 30, 2024
GAITHERSBURG, Md. and NESS ZIONA, Israel, May 30, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the […]
Read More
Uncategorized - May 30, 2024
Late-breaking presentation of data at American Transplant Congress on Monday, June 3 Data show potential to monitor for therapeutic efficacy […]
Read More
Uncategorized - May 30, 2024
MIAMI, May 30, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with […]
Read More
Uncategorized - May 30, 2024
Leiden, the Netherlands, May 30, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an […]
Read More
Uncategorized - May 30, 2024
Châtillon, France, May 30, 2024 DBV Technologies to Participate in Upcoming EAACI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: […]
Read More
Uncategorized - May 30, 2024
WASHINGTON, May 30, 2024 (GLOBE NEWSWIRE) — IBEX Limited (NASDAQ: IBEX) What’s happening? IBEX Limited (NASDAQ: IBEX) (“ibex”), a leading […]
Read More
Uncategorized - May 30, 2024
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company […]
Read More